Choose Your GLOW Product
Compare the ingredient amounts and format, then select your product. The two vials contain freeze-dried material; the autoinjector contains a preloaded solution.
GLOW Blend 50 mg
LYOPHILIZED / 3 mL VIALThe 35 / 5 / 10 mg formulation.
- GHK-Cu
- 35 mg
- BPC-157
- 5 mg
- TB-500 (Thymosin beta-4)
- 10 mg
Lot PL-2609-042
GLOW Blend 70 mg
LYOPHILIZED / 3 mL VIALThe 50 / 10 / 10 mg formulation.
- GHK-Cu
- 50 mg
- BPC-157
- 10 mg
- TB-500 (Thymosin beta-4)
- 10 mg
Lot PL-2609-043
GLOW Autoinjector
PRELOADED / 3 mL PENThe preloaded solution format.
- GHK-Cu
- 107 mg
- BPC-157
- 21.4 mg
- TB-500 (Thymosin beta-4)
- 21.4 mg
Manufacturer-declared contents
Vial quantities and reported test results come from the named manufacturer certificates. Pen contents and concentration follow the supplied manufacturer specification.
50 mg or 70 mg: Compare the Ingredients
The 70 mg vial contains 15 mg more GHK-Cu and 5 mg more BPC-157 than the 50 mg vial. Both contain 10 mg TB-500 (Thymosin beta-4). Choose by the composition required for your research, not the total weight alone.
Ingredient quantities in mg. Both bars use the same scale. These are container contents, not administration amounts.
35 / 5 / 10 mg
GHK-Cu, BPC-157 and TB-500, respectively. The labeled ingredient mass ratio is 7:1:2.
50 / 10 / 10 mg
GHK-Cu, BPC-157 and TB-500, respectively. The labeled ingredient mass ratio is 5:1:1.
Freeze-dried blend
The 3 mL designation describes vial capacity, not a supplied liquid fill or a ready-made concentration.
GLOW Autoinjector: The Details in One Place
3 mL solution at 50 mg/mL
The product is labeled as 150 mg total blend. Its supplied specification lists GHK-Cu 107 mg, BPC-157 21.4 mg and TB-500 (Thymosin beta-4) 21.4 mg per pen.
The documented format is an aqueous solution in bacteriostatic water containing 0.9% benzyl alcohol, supplied in a 3 mL glass cartridge inside the preloaded device.
Select Autoinjector ↑The specification identifies a 5:1:1 ingredient mass ratio, matching the ratio of the 70 mg vial. It is a different presentation and total labeled quantity, not a 70 mg vial placed inside a pen.
Sealed storage: the supplied pen specification states 2-8 °C in the original carton, protected from light. Its safety data sheet identifier is PL-SDS-070. Use the instructions for the actual supplied product.
Product specifications are available on Quality + COA. Concentration and container amounts are not a personal dosing schedule.
Review the Original Vial COAs
Open the original two-page certificate for either vial formulation. Each record identifies the product lot, methods, reported results and approval details.
GLOW Blend 50 mg
Lot PL-2609-042
Certificate PL-26-00042
GLOW Blend 70 mg
Lot PL-2609-043
Certificate PL-26-00043
These records were issued by PrymaLab Analytical, the manufacturer's in-house laboratory. Results apply to the named sampled lots; no independent third-party testing is claimed.
Use the Quality + COA report library to inspect both documents, compare the methods and find the issuer's verification details. Confirm the lot supplied with your order against its matching record.
From Product Selection to Checkout
Choose the format
Select a 50 mg vial, 70 mg vial or preloaded autoinjector. Check the ingredient amounts rather than choosing solely by pack weight.
Review the details
Read the product specification and available documentation. Confirm the price, quantity, delivery charges and seller's purchasing conditions.
Continue to the seller
The product button connects to the configured seller destination. The seller handles payment, order confirmation and fulfillment.
Compare like-for-like products when considering price. A different ingredient ratio, fill volume or format changes what is being purchased. We do not assume a treatment cycle or a monthly supply from a container's milligram amount.
For product or purchasing enquiries, email [email protected].
Buying GLOW: Frequently Asked Questions
Which GLOW products can I compare here?−
The 50 mg and 70 mg freeze-dried vial formulations, plus the preloaded 3 mL autoinjector. All three use the ingredient labels GHK-Cu, BPC-157 and TB-500 (Thymosin beta-4).
How do the 50 mg and 70 mg vials differ?−
The 50 mg vial declares 35 mg GHK-Cu, 5 mg BPC-157 and 10 mg TB-500. The 70 mg vial declares 50 mg, 10 mg and 10 mg, respectively. Their ingredient ratios differ; the 70 mg vial is not simply a proportionally larger 50 mg formulation.
What is in the GLOW autoinjector?−
The supplied specification lists GHK-Cu 107 mg, BPC-157 21.4 mg and TB-500 (Thymosin beta-4) 21.4 mg in a 3 mL solution. The product is labeled 50 mg/mL and 150 mg total blend.
Are the vials supplied as a solution?−
No. The two supplied vial records describe lyophilized co-blend powder. A 3 mL vial capacity is not a stated solution fill. The autoinjector is the preloaded liquid format.
Where can I see the original certificates?−
Open the 50 mg or 70 mg COA above, or use the Quality + COA page. The complete two-page records retain their original issuer details and verification information.
Are these independent laboratory reports?−
The supplied certificates explicitly identify the manufacturer's in-house laboratory. We preserve that attribution and the named lot results rather than describe them as independent testing.
Where can I ask about a specification or an order?−
Use Contact for website and document enquiries. For a completed order, use the seller contact on the order confirmation. Do not send payment-card details or medical records by email.
Choose Your GLOW Format
Compare the vial formulations or go straight to the preloaded autoinjector.
Product Specifications and Source Records
- 1GLOW 50 mg certificate
Lot PL-2609-042. Manufacturer-declared composition and in-house reported test results. - 2GLOW 70 mg certificate
Lot PL-2609-043. Manufacturer-declared composition and in-house reported test results. - 3Autoinjector specification
Supplied manufacturer specification screenshot. Declared fill, ingredient amounts, form and sealed-storage details.
